U.S. flag

An official website of the United States government

NM_207346.3(TSEN54):c.919G>T (p.Ala307Ser) AND multiple conditions

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Sep 1, 2017
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000515314.7

Allele description [Variation Report for NM_207346.3(TSEN54):c.919G>T (p.Ala307Ser)]

NM_207346.3(TSEN54):c.919G>T (p.Ala307Ser)

Gene:
TSEN54:tRNA splicing endonuclease subunit 54 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17q25.1
Genomic location:
Preferred name:
NM_207346.3(TSEN54):c.919G>T (p.Ala307Ser)
HGVS:
  • NC_000017.11:g.75522000G>T
  • NG_013041.1:g.10473G>T
  • NM_207346.3:c.919G>TMANE SELECT
  • NP_997229.2:p.Ala307Ser
  • NC_000017.10:g.73518081G>T
  • NM_207346.2:c.919G>T
  • Q7Z6J9:p.Ala307Ser
Protein change:
A307S; ALA307SER
Links:
UniProtKB: Q7Z6J9#VAR_054813; OMIM: 608755.0001; OMIM: 608755.0002; dbSNP: rs113994152
NCBI 1000 Genomes Browser:
rs113994152
Molecular consequence:
  • NM_207346.3:c.919G>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Pontocerebellar hypoplasia type 4 (PCH4)
Synonyms:
Encephalopathy fatal infantile with olivopontocerebellar hypoplasia
Identifiers:
MONDO: MONDO:0009166; MedGen: C1856974; Orphanet: 166063; OMIM: 225753
Name:
Pontocerebellar hypoplasia type 2A (PCH2A)
Synonyms:
PONTOCEREBELLAR HYPOPLASIA WITH PROGRESSIVE CEREBRAL ATROPHY; VOLENDAM NEURODEGENERATIVE DISEASE
Identifiers:
MONDO: MONDO:0010190; MedGen: C1848526; Orphanet: 2524; OMIM: 277470

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000807649Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Sep 1, 2017)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

tRNA splicing endonuclease mutations cause pontocerebellar hypoplasia.

Budde BS, Namavar Y, Barth PG, Poll-The BT, Nürnberg G, Becker C, van Ruissen F, Weterman MA, Fluiter K, te Beek ET, Aronica E, van der Knaap MS, Höhne W, Toliat MR, Crow YJ, Steinling M, Voit T, Roelenso F, Brussel W, Brockmann K, Kyllerman M, Boltshauser E, et al.

Nat Genet. 2008 Sep;40(9):1113-8. doi: 10.1038/ng.204.

PubMed [citation]
PMID:
18711368

Recurrent episodes of rhabdomyolysis in pontocerebellar hypoplasia type 2.

Zafeiriou DI, Ververi A, Tsitlakidou A, Anastasiou A, Vargiami E.

Neuromuscul Disord. 2013 Feb;23(2):116-9. doi: 10.1016/j.nmd.2012.08.004. Epub 2012 Nov 22.

PubMed [citation]
PMID:
23177318
See all PubMed Citations (5)

Details of each submission

From Baylor Genetics, SCV000807649.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing
(GTR000508680.4)
PubMed (5)

Description

This variant has been previously reported as disease-causing and was found six times in our laboratory, either homozygous or compound heterozygous, in individuals with pontocerebellar hypoplasia. Heterozygotes would be expected to be asymptomatic carriers.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided
(GTR000508680.4)
not providednot providednot providednot provided

Last Updated: Nov 10, 2024